Cargando…

Serotonin syndrome by drug interactions with linezolid: clues from pharmacovigilance-pharmacokinetic/pharmacodynamic analysis

PURPOSE: To characterize the post-marketing reporting of serotonin syndrome (SS) due to drug-drug interactions (DDIs) with linezolid and investigate the relationship with pharmacokinetic/pharmacodynamic (PK/PD) properties of serotonergic agents. METHODS: We queried the worldwide FDA Adverse Event Re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gatti, Milo, Raschi, Emanuel, De Ponti, Fabrizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Pharmacoepidemiology and Prescription
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803711/ https://www.ncbi.nlm.nih.gov/pubmed/32901348 http://dx.doi.org/10.1007/s00228-020-02990-1

Ejemplares similares

Pharmacovigilance in children in Camagüey Province, Cuba
por: Bárzaga Arencibia, Z., et al.
Publicado: (2012)

Renal ischemic adverse drug events related to tranexamic acid in women of child-bearing age: an analysis of pharmacovigilance data
por: Stämpfli, Dominik, et al.
Publicado: (2020)

Coadministration of tizanidine and ciprofloxacin: a retrospective analysis of the WHO pharmacovigilance database
por: Rudolph, Annette, et al.
Publicado: (2021)

Role of pharmacoepidemiology studies in addressing pharmacovigilance questions: a case example of pancreatitis risk among ulcerative colitis patients using mesalazine
por: Russo, Leo, et al.
Publicado: (2014)

Clinically relevant drug–drug interactions among elderly people with dementia
por: Sönnerstam, Eva, et al.
Publicado: (2018)

Drug interaction alerts in older primary care patients, and related medically justified actions
por: Tukukino, Carina, et al.
Publicado: (2022)

Bleeding and thromboembolism due to drug-drug interactions with non-vitamin K antagonist oral anticoagulants—a Swedish, register-based cohort study in atrial fibrillation outpatients
por: Holm, Johan, et al.
Publicado: (2020)

Drug use in pregnant women—a pilot study of the coherence between reported use of drugs and presence of drugs in plasma
por: Wolgast, Emelie, et al.
Publicado: (2017)

Sex differences in spontaneous reports on adverse drug events for common antihypertensive drugs
por: Rydberg, Diana M, et al.
Publicado: (2018)

Use of rivaroxaban in Germany: a database drug utilization study of a drug started in hospital
por: Jobski, Kathrin, et al.
Publicado: (2014)

Prevalence of suboptimal drug treatment in patients with and without multidose drug dispensing—a cross-sectional study
por: Belfrage, Björn, et al.
Publicado: (2014)

Correct use of non-indexed eGFR for drug dosing and renal drug-related problems at hospital admission
por: Seiberth, Sarah, et al.
Publicado: (2020)

Predictors of orphan drug approval in the European Union
por: Heemstra, Harald E., et al.
Publicado: (2008)

Non-persistence to antihypertensive drug therapy in Lithuania
por: Treciokiene, Indre, et al.
Publicado: (2022)

Factors associated with time consumption when answering drug-related queries to Scandinavian drug information centres: a multi-centre study
por: Reppe, Linda Amundstuen, et al.
Publicado: (2014)

Are multidose drug dispensing systems initiated for the appropriate patients?
por: Mertens, Bram J., et al.
Publicado: (2018)

Motives for reporting adverse drug reactions by patient-reporters in the Netherlands
por: van Hunsel, Florence, et al.
Publicado: (2010)

Systematic review of safety in paediatric drug trials published in 2007
por: Nor Aripin, Khairun Nain Bin, et al.
Publicado: (2011)

In utero exposure to antidepressants and the use of drugs for pulmonary diseases in children
por: ter Horst, P. G. J., et al.
Publicado: (2012)

Recognition of adverse drug events in older hospitalized medical patients
por: Klopotowska, Joanna E., et al.
Publicado: (2012)

Trends in inpatient antiparkinson drug use in the USA, 2001–2012
por: Crispo, James A. G., et al.
Publicado: (2015)

Aggregation and analysis of indication-symptom relationships for drugs approved in the USA
por: Punyala, Ananth, et al.
Publicado: (2020)

Number of medications and adverse drug events by unintentional poisoning among older adults in consideration of inappropriate drug use: a Swedish population-based matched case-control study
por: Rausch, Christian, et al.
Publicado: (2017)

Outcomes of off-label drug uses in hospitals: a multicentric prospective study
por: Danés, I., et al.
Publicado: (2014)

The changing multiple sclerosis treatment landscape: impact of new drugs and treatment recommendations
por: Eriksson, Irene, et al.
Publicado: (2018)

Drug utilisation in neonatal units in England and Wales: a national cohort study
por: Al-Turkait, Asma, et al.
Publicado: (2022)

Colorectal cancer chemotherapy: can sex-specific disparities impact on drug toxicities?
por: De Francia, Silvia, et al.
Publicado: (2022)

Regulatory scientific advice in drug development: does company size make a difference?
por: Putzeist, Michelle, et al.
Publicado: (2010)

Discrepancies between prescribed and defined daily doses: a matter of patients or drug classes?
por: Grimmsmann, Thomas, et al.
Publicado: (2011)

Do medical students copy the drug treatment choices of their teachers or do they think for themselves?
por: Tichelaar, J., et al.
Publicado: (2009)

Potentially inappropriate prescribing and adverse drug reactions in the elderly: a population-based study
por: Hedna, Khedidja, et al.
Publicado: (2015)

The 10-year trend in drug prescriptions for attention-deficit/hyperactivity disorder (ADHD) in Germany
por: Grimmsmann, Thomas, et al.
Publicado: (2020)

Incidence, preventability, and causality of adverse drug reactions at a university hospital emergency department
por: Kauppila, Mirjam, et al.
Publicado: (2020)

The potential of training specialist oncology nurses in real-life reporting of adverse drug reactions
por: Reumerman, M., et al.
Publicado: (2021)

Frequency of laboratory measurement and hyperkalaemia in hospitalised patients using serum potassium concentration increasing drugs
por: Uijtendaal, Esther V., et al.
Publicado: (2011)

Majority of drug-related problems identified during medication review are not associated with STOPP/START criteria
por: Verdoorn, Sanne, et al.
Publicado: (2015)

Vitamin D deficiency as adverse drug reaction? A cross-sectional study in Dutch geriatric outpatients
por: van Orten-Luiten, A. C. B., et al.
Publicado: (2016)

Relationship between drug burden and physical and cognitive functions in a sample of nursing home patients with dementia
por: Sanders, L. M. J., et al.
Publicado: (2017)

Adequate, questionable, and inadequate drug prescribing for older adults at the end of life: a European expert consensus
por: Morin, Lucas, et al.
Publicado: (2018)

Quality assessment of structure and language elements of written responses given by seven Scandinavian drug information centres
por: Reppe, Linda Amundstuen, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1c93uff3rf6d9nq36e2h1mpnb2